首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1565708

分子靶向诊断市场，按产品、按应用、按技术、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Molecular Targeted Diagnostics Market, By Product, By Application, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年10月02日 | 出版商:

AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3个工作天内

价格

简介目录

报告要点

2023年分子标靶诊断市场规模为154.0833亿美元，2024年至2032年复合年增长率为7.02%。

分子标靶诊断市场-市场动态

癌症盛行率的增加以及早期和准确检测的需求，筛检预计将推动市场需求

全球癌症发生率不断上升，导致对能够及早准确检测癌症的诊断方法的需求不断增加。分子诊断为驱动肿瘤生长的基因改变提供了宝贵的见解，从而透过标靶治疗获得更好的结果。人们对遗传性疾病和罕见疾病的认识不断增强，以及对早期准确检测的需求，增加了对分子标靶诊断的需求，从而促进了市场成长。这些测试有助于识别遗传性疾病并协助产前筛检和新生儿检测。

人们对早期诊断和筛检预防疾病进展的认识不断提高，推动了对分子标靶诊断的需求。公共卫生措施正在推动癌症、遗传性疾病和传染病筛检计画的采用。由于个人化医疗的进步、癌症和遗传疾病盛行率的增加、技术创新以及液体活检等非侵入性诊断技术的广泛使用，分子标靶诊断市场正在经历显着增长。

分子标靶诊断市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 7.02% 左右的复合年增长率成长

根据产品细分，由于诊所和研究行业的高度采用，预计试剂细分市场将在 2023 年显示最大的市场份额。

根据应用细分，由于传染病和病毒性疾病的盛行率不断上升，传染病领域是 2023 年领先的应用领域。

从技术细分来看，由于对治疗传染病的高需求，聚合酶链反应（PCR）领域将成为 2023 年领先的技术领域。

从地区来看，由于政府在新药开发方面的支持倡议，北美将成为 2023 年的主要收入来源。

分子标靶诊断市场-細項分析：

全球分子标靶诊断市场根据产品、应用、技术和地区进行细分。

市场依产品分为三类：仪器、试剂和其他。试剂细分市场占据主导地位。新颖测试的日益采用和研究活动的不断增加正在促进市场成长。

市场依应用分为六类：传染病、药物基因体学、肿瘤学、基因检测、微生物学等。传染病细分市场占据主导地位。分子诊断对于传染病治疗是有效且至关重要的，这是增加市场成长的主要因素。

根据技术，市场分为五大类：PCR、晶片和微阵列、质谱、定序等。 PCR 领域在市场上占据主导地位，预计在预测期内将保持其高度主导地位。 COVID-19 和其他传染病的不断出现推动了对分子诊断需求的需求。

分子标靶诊断市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。在医疗保健投资增加、癌症发病率上升以及先进诊断技术更广泛采用的推动下，亚太地区正在经历显着增长。中国是该地区的主要驱动力，拥有快速成长的精准医疗市场、政府对基因研究的支持以及癌症盛行率的上升。欧洲是分子标靶诊断市场的另一个重要参与者，以德国、英国和法国等国家为首。美国在创新方面处于领先地位，拥有大量临床试验和伴随诊断的批准。

分子标靶诊断市场-竞争格局：

分子标靶诊断市场竞争激烈，拥有许多成熟企业和创新新创公司。技术进步、合作关係以及对精准医疗不断增长的需求推动了竞争。公司专注于获得伴随诊断的监管批准，特别是在美国和欧洲。扩展到亚太和拉丁美洲等新兴市场也是许多公司的关键成长策略。多家公司正在与製药公司建立合作关係，共同开发伴随诊断技术。这种趋势在肿瘤学领域尤其强烈，罗氏、凯杰和赛默飞世尔等公司正在引领癌症标靶治疗诊断技术的开发。

2024 年 7 月，赛默飞世尔科技完成了对 Olink Holdings AB 的收购，以扩大其在欧洲的业务范围。

2022 年，Illumina Inc. 开发了多种针对癌症的面板，包括用于全面基因组分析的 TruSight Oncology 500。

2021 年，罗氏收购了 GenMark Diagnostics，扩大了其在多重分子诊断领域的产品组合。

介绍
- 按地理位置分類的细分市场占有率分析
北美洲
- 概述
- 北美分子靶向诊断主要製造商
- 北美市场规模和预测（按国家）
- 北美市场规模和预测（按产品）
- 北美市场规模和预测（按应用）
- 北美市场规模和预测（按技术）
- 我们
- 加拿大
欧洲
- 概述
- 欧洲分子靶向诊断主要製造商
- 欧洲市场规模和预测（按国家）
- 欧洲市场规模和预测（按产品）
- 欧洲市场规模和预测（按应用）
- 欧洲市场规模与预测（按技术）
- 德国
- 义大利
- 英国
- 法国
- 俄罗斯
- 荷兰
- 瑞典
- 波兰
- 欧洲其他地区
亚太地区 (APAC)
- 概述
- 亚太地区分子标靶诊断主要製造商
- 亚太地区市场规模与预测（按国家）
- 亚太地区市场规模与预测（按产品）
- 亚太地区市场规模与预测（按应用）
- 亚太地区市场规模与预测（按技术）
- 印度
- 中国
- 日本
- 韩国
- 澳洲
- 泰国
- 印尼
- 菲律宾
- 亚太地区其他地区
拉丁美洲
- 概述
- 拉丁美洲分子靶向诊断主要製造商
- 拉丁美洲市场规模与预测（按国家）
- 拉丁美洲市场规模与预测（按产品）
- 拉丁美洲市场规模与预测（按应用）
- 拉丁美洲市场规模与预测（按技术）
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 拉丁美洲其他地区
中东和非洲
- 概述
- 中东和非洲分子靶向诊断主要製造商
- 中东和非洲市场规模及预测（按国家）
- 中东和非洲市场规模及预测（按产品）
- 中东和非洲市场规模及预测（按应用）
- 中东和非洲市场规模及预测（按技术）
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 以色列
- 土耳其
- 阿尔及利亚
- 埃及
- MEA 的其余部分

第 11 章：主要供应商分析 - 分子标靶诊断产业

竞争仪表板
公司简介
- Thermo Fisher Scientific
- Qiagen NV
- Abbott Laboratories
- Illumina, Inc.
- Agilent Technologies
- Bio-Rad Laboratories
- Becton, Dickinson and Company (BD)
- Hologic, Inc.
- Myriad Genetics, Inc.
- Siemens Healthineers
- Danaher Corporation
- Genomic Health
- Sysmex Corporation
- Grifols SA
- bioMerieux SA
- Others

第 12 章：360 度分析师视角

第 13 章：附录

研究方法
参考
缩写
免责声明
联络我们

简介目录

Product Code: ANV3905

REPORT HIGHLIGHT

Molecular Targeted Diagnostics Market size was valued at USD 15,408.33 Million in 2023, expanding at a CAGR of 7.02% from 2024 to 2032.

Molecular targeted diagnostics focuses on identifying specific molecular markers in a patient's body usually in cells, tissues, or bodily fluids. These molecular markers often include DNA, RNA, proteins, and other biomolecules. The primary purpose is to detect abnormalities at the molecular level that may be indicative of diseases such as cancer, cardiovascular disorders, or genetic conditions.

Molecular Targeted Diagnostics Market- Market Dynamics

Increasing prevalence of cancer and the need for early & accurate detection, screening is expected to propel market demand

The rising global incidence of cancer has led to an increased need for diagnostic methods that can detect cancers early and accurately. Molecular diagnostics provide valuable insights into the genetic alterations that drive tumor growth, leading to better outcomes with targeted therapies. The growing awareness of genetic disorders and rare diseases, as well as the need for early and accurate detection, is increasing the demand for molecular targeted diagnostics, thereby boosting market growth. These tests help in identifying hereditary conditions and assist in prenatal screening and newborn testing.

Growing awareness of early diagnosis and screening in preventing disease progression is driving the demand for molecular targeted diagnostics. Public health initiatives are promoting the adoption of screening programs for cancer, genetic disorders, and infectious diseases. The molecular targeted diagnostics market is experiencing significant growth due to advancements in personalized medicine, the increasing prevalence of cancer and genetic diseases, technological innovations, and the expanding use of non-invasive diagnostic techniques like liquid biopsy.

Molecular Targeted Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.02% over the forecast period (2024-2032)

Based on Product segmentation, the reagents segment was predicted to show maximum market share in the year 2023, owing to high adoption in clinics & research industry.

Based on Application segmentation, infectious diseases segment was the leading Application segment in 2023, due to the growing prevalence of infectious & viral disorders.

Based on Technology segmentation, polymerase chain reaction (PCR) segment was the leading Technology segment in 2023, due to high demand for treating infectious diseases.

On the basis of region, North America was the leading revenue generator in 2023, due to the supportive government initiatives in new drugs development.

Molecular Targeted Diagnostics Market- Segmentation Analysis:

The Global Molecular Targeted Diagnostics Market is segmented on the basis of Product, Application, Technology, and Region.

The market is divided into three categories based on Product: instruments, reagents, and others. The reagents segment dominates the market. The increasing adoption of novel tests and growing research activities is fostering market growth.

The market is divided into six categories based on Application: infectious diseases, pharmacogenomics, oncology, genetic testing, microbiology, and others. The infectious diseases segment dominates the market. The molecular diagnosis is effective & vital in infectious disorders cure which is the main factor increasing market growth.

The market is divided into five categories based on Technology: PCR, chips & microarrays, mass spectrometry, sequencing, and others. The PCR segment dominates the market and is expected to maintain its high dominance during the forecast period. The growing emergence during COVID-19 and other infectious diseases have fueled the demand for molecular diagnostics demand.

Molecular Targeted Diagnostics Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Asia Pacific is witnessing significant growth, driven by increasing healthcare investments, rising cancer incidences, and greater adoption of advanced diagnostics. China is a major driver in the region, with a rapidly growing precision medicine market, government support for genetic research, and an increasing prevalence of cancer. Europe is another significant player in the molecular targeted diagnostics market, led by countries like Germany, the U.K., and France. The U.S. leads in innovation, with numerous clinical trials and approvals of companion diagnostics.

Molecular Targeted Diagnostics Market- Competitive Landscape:

The Molecular Targeted Diagnostics market is highly competitive and features numerous established players and innovative startups. The competition is driven by advancements in technology, partnerships, and the rising demand for precision medicines. Companies are focused on obtaining regulatory approvals for companion diagnostics, particularly in the U.S. and Europe. Expanding into emerging markets, such as Asia-Pacific and Latin America, is also a key growth strategy for many firms. Several companies are forming partnerships with pharmaceutical firms to co-develop companion diagnostics. This trend is particularly strong in oncology, where companies like Roche, Qiagen, and Thermo Fisher are leading the development of diagnostics for targeted cancer therapies.

In July 2024, Thermo Fisher Scientific completed the acquisition of Olink Holdings AB to expand their reach across Europe.

In 2022, Illumina Inc., has developed several cancer-focused panels, including the TruSight Oncology 500, which is used for comprehensive genomic profiling.

In 2021, Roche acquired GenMark Diagnostics, expanding its portfolio in multiplex molecular diagnostics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET KEY PLAYERS

Thermo Fisher Scientific
Qiagen N.V.
Abbott Laboratories
Illumina, Inc.
Agilent Technologies
Bio-Rad Laboratories
Becton, Dickinson and Company (BD)
Hologic, Inc.
Myriad Genetics, Inc.
Siemens Healthineers
Danaher Corporation
Genomic Health
Sysmex Corporation
Grifols SA
bioMerieux SA
Others

GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

Instruments
Reagents
Others

GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

Infectious diseases
Pharmacogenomics
Oncology
Genetic testing
Microbiology
Others

GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019-2032

PCR
Chips & microarrays
Mass spectrometry
Sequencing
Others

GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Molecular Targeted Diagnostics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Molecular Targeted Diagnostics Market Snippet by Product
- 2.1.2. Molecular Targeted Diagnostics Market Snippet by Application
- 2.1.3. Molecular Targeted Diagnostics Market Snippet by Technology
- 2.1.4. Molecular Targeted Diagnostics Market Snippet by Country
- 2.1.5. Molecular Targeted Diagnostics Market Snippet by Region
2.2. Competitive Insights

3. Molecular Targeted Diagnostics Key Market Trends

3.1. Molecular Targeted Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Molecular Targeted Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Molecular Targeted Diagnostics Market Opportunities
3.4. Molecular Targeted Diagnostics Market Future Trends

4. Molecular Targeted Diagnostics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Molecular Targeted Diagnostics Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Molecular Targeted Diagnostics Market Landscape

6.1. Molecular Targeted Diagnostics Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Molecular Targeted Diagnostics Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
- 7.1.2. Instruments
- 7.1.3. Reagents
- 7.1.4. Others

8. Molecular Targeted Diagnostics Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 8.1.2. Infectious diseases
- 8.1.3. Pharmacogenomics
- 8.1.4. Oncology
- 8.1.5. Genetic testing
- 8.1.6. Microbiology
- 8.1.7. Others

9. Molecular Targeted Diagnostics Market - By Technology

9.1. Overview
- 9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
- 9.1.2. PCR
- 9.1.3. Chips & microarrays
- 9.1.4. Mass spectrometry
- 9.1.5. Sequencing
- 9.1.6. Others

10. Molecular Targeted Diagnostics Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Molecular Targeted Diagnostics Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Molecular Targeted Diagnostics Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Molecular Targeted Diagnostics Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Molecular Targeted Diagnostics Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Molecular Targeted Diagnostics Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Molecular Targeted Diagnostics Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Thermo Fisher Scientific
- 11.2.2. Qiagen N.V.
- 11.2.3. Abbott Laboratories
- 11.2.4. Illumina, Inc.
- 11.2.5. Agilent Technologies
- 11.2.6. Bio-Rad Laboratories
- 11.2.7. Becton, Dickinson and Company (BD)
- 11.2.8. Hologic, Inc.
- 11.2.9. Myriad Genetics, Inc.
- 11.2.10. Siemens Healthineers
- 11.2.11. Danaher Corporation
- 11.2.12. Genomic Health
- 11.2.13. Sysmex Corporation
- 11.2.14. Grifols SA
- 11.2.15. bioMerieux SA
- 11.2.16. Others